1 MONTELUKAST SODIUM | 90 of 940 | 3020 prescriptions Less than 1% of all prescriptions | 2370 | 940 patients 31% of all patients | 770 patients 25% of all patients | |
2 AZITHROMYCIN | 60 of 800 | 1420 prescriptions Less than 1% of all prescriptions | | 420 patients 14% of all patients | < 11 | A |
3 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 270 of 990 | 1190 prescriptions Less than 1% of all prescriptions | 990 | 430 patients 14% of all patients | < 11 | |
4 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 210 of 910 | 1030 prescriptions Less than 1% of all prescriptions | 910 | 290 patients 10% of all patients | < 11 | |
5 VENTOLIN HFA (ALBUTEROL SULFATE) | 470 of 1070 | 990 prescriptions Less than 1% of all prescriptions | 810 | 520 patients 17% of all patients | 380 patients 13% of all patients | |
6 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 470 of 1020 | 910 prescriptions Less than 1% of all prescriptions | | 260 patients 9% of all patients | < 11 | |
7 PROAIR HFA (ALBUTEROL SULFATE) | 160 of 790 | 790 prescriptions Less than 1% of all prescriptions | 630 | 330 patients 11% of all patients | < 11 | |
8 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 180 of 720 | 700 prescriptions Less than 1% of all prescriptions | | 220 patients 7% of all patients | < 11 | |
9 DALIRESP (ROFLUMILAST) | 120 of 510 | 550 prescriptions Less than 1% of all prescriptions | | 170 patients 6% of all patients | < 11 | |
10 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 440 of 930 | 530 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
11 SPIRIVA (TIOTROPIUM BROMIDE) | 370 of 820 | 360 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
12 FLUTICASONE PROPIONATE | 270 of 780 | 430 prescriptions Less than 1% of all prescriptions | 300 | 140 patients 5% of all patients | < 11 | |
13 AZELASTINE HCL | 70 of 240 | 350 prescriptions Less than 1% of all prescriptions | | 180 patients 6% of all patients | < 11 | |
14 SUCRALFATE | 10 | 210 prescriptions Less than 1% of all prescriptions | | 110 patients 4% of all patients | < 11 | |
15 PREDNISONE | 560 of 1100 | 560 prescriptions Less than 1% of all prescriptions | | 410 patients 14% of all patients | < 11 | |
16 STIOLTO RESPIMAT (TIOTROPIUM BR/OLODATEROL HCL) | 230 of 520 | 280 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
17 THEOPHYLLINE ANHYDROUS | 70 of 190 | 310 prescriptions Less than 1% of all prescriptions | 310 | < 11 | < 11 | |
18 TRELEGY ELLIPTA (FLUTICASONE/UMECLIDIN/VILANTER) | 390 of 740 | 240 prescriptions Less than 1% of all prescriptions | | 160 patients 5% of all patients | < 11 | |
19 OMEPRAZOLE | 220 of 370 | 190 prescriptions Less than 1% of all prescriptions | 190 | < 11 | < 11 | |
20 METOCLOPRAMIDE HCL | 30 of 50 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
21 ELIQUIS (APIXABAN) | 110 of 220 | 220 prescriptions Less than 1% of all prescriptions | 220 | < 11 | < 11 | |
22 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 690 of 930 | 210 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
23 THEOPHYLLINE (THEOPHYLLINE ANHYDROUS) | 70 of 150 | 190 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
24 ESOMEPRAZOLE MAGNESIUM | 90 of 140 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
25 ARNUITY ELLIPTA (FLUTICASONE FUROATE) | 180 of 340 | 140 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
26 ESBRIET (PIRFENIDONE) | 140 of 270 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
27 LEVOFLOXACIN | 50 of 480 | 520 prescriptions Less than 1% of all prescriptions | | 450 patients 15% of all patients | < 11 | A |
28 PROLASTIN C (ALPHA-1-PROTEINASE INHIBITOR) | 10 of 40 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
29 SILDENAFIL (SILDENAFIL CITRATE) | 150 of 260 | 120 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
30 CEFDINIR | 60 of 60 | 120 prescriptions Less than 1% of all prescriptions | | 120 patients 4% of all patients | < 11 | A |